Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea · Delayed Price · Currency is KRW 90,200
+1,900 (2.15%)
Jul 7, 2026, 12:05 PM KST
Kolon TissueGene Market Cap
Kolon TissueGene has a market cap or net worth of 7.5 trillion as of July 6, 2026. Its market cap has increased by 129.86% in one year.
Market Cap
7.50T
Enterprise Value
7.45T
Revenue
5.28B
Ranking
n/a
PE Ratio
n/a
Stock Price
90,200.00
Market Cap Chart
Since November 6, 2017, Kolon TissueGene's market cap has increased from 2.58T to 7.50T, an increase of 191.01%. That is a compound annual growth rate of 13.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 7.50T | 13.26% |
| Dec 30, 2025 | 6.62T | 258.54% |
| Dec 30, 2024 | 1.85T | 181.73% |
| Dec 28, 2023 | 655.80B | 7.08% |
| Dec 29, 2022 | 612.43B | -76.74% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 18.29T |
| Samsung Epis Holdings | 10.36T |
| SK Biopharmaceuticals | 6.75T |
| HLB Co., Ltd. | 6.43T |
| LigaChem Biosciences | 4.93T |
| Peptron | 4.21T |
| D&D Pharmatech | 3.63T |
| Voronoi | 3.22T |